e-Therapeutics success in £17 million financing
February 17, 2011Research and Development, Sales and Marketing ETS2101, Invesco, e-Therapeutics
UK drug discovery and development company e-Therapeutics has successfully raised £17.6 million through a new share issue. The deal attracted …
Pharma industry R&D pipelines
February 16, 2011Research and Development pipeline, pipelines
New medicines which advance the treatment of diseases are the lifeblood of the pharmaceutical industry, and billions are invested by …
Lilly hails progress of new R&D approaches
February 16, 2011Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly
Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …
Companies join forces to promote AF awareness
February 16, 2011Medical Communications, Sales and Marketing AF, Multaq, Pradaxa, apixaban, atrial fibrillation
Boehringer Ingelheim and Sanofi-Aventis are to co-sponsor the World Heart Federation’s global atrial fibrillation (AF) education campaign. AF AWARE was …
Sanofi seals Genzyme deal for $20 billion
February 16, 2011Research and Development, Sales and Marketing Genzyme, Sanofi
Sanofi-Aventis has finally agreed a deal to buy Genzyme for $20.1 billion after eight months of wrangling with the US …
Sefton takes over at Ketchum Pleon healthcare
February 16, 2011Medical Communications Ketchum Pleon, PR, appointment, medical communications, recruitment
Ketchum Pleon, the leading communications consultancy in the UK and Europe, has announced today that Amanda Sefton has been named …
Obama’s generics plan criticised
February 15, 2011Sales and Marketing FDA, Obama, PhRMA, generics, reform
US pharma says new plans to end ‘pay-for-delay’ generics deals and shave five years from biologics exclusivity will threaten innovation …
Sartorius reaps rewards from Asian boom
February 15, 2011Manufacturing and Production
German lab and processing equipment group Sartorius reported a bumper year in 2010, with revenues up nearly 10% on the …
Merck repels jaw injury claim
February 15, 2011Sales and Marketing Fosamax, Merck, US, lawsuit
A New Jersey state court jury has found in favour of Merck & Co in the company’s ongoing legal battle …
US Senate takes aim at prescription drug shortages
February 15, 2011Manufacturing and Production Merck, Zostavax, shortages, supply chain
A bill aimed at tackling the ongoing problem of prescription drug shortages in the US has been introduced in the …
Insulin pens help Gerresheimer to record sales
February 15, 2011Manufacturing and Production Gerresheimer, glass, packaging, plastic
Gerresheimer has posted a bumper set of results in 2010, thanks to continuing strong demand for its glass and plastic …
Sale of Organon facility in Oss may avert closure
February 15, 2011Manufacturing and Production Merck & Co, Netherlands, Oss
The fate of an Organon manufacturing and R&D facility in the Netherlands, currently under threat of closure by parent company …
R&D productivity worse than previously reported
February 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing BIO, BMT, FDA, R&D
A new analysis of pharma’s R&D pipelines suggests the overall success rate for drugs moving from clinical trials to FDA …
Pharmaceutical manufacturing news in brief
February 15, 2011Manufacturing and Production Boehringer Ingelheim, DSM Biologics, Elan, Novasep
Irish drugmaker Elan has forged an alliance with Boehringer Ingelheim to develop and manufacture antibody-based therapeutics. Under the terms of …
Medivir and Janssen in dengue fever research alliance
February 14, 2011Research and Development Dengue fever, Medivir
Medivir, the speciality pharma company focused on infectious diseases, it to collaborate with Janssen on discovering and developing new medicines …
Germany’s Merck pledges emphasis on women executives
February 14, 2011Sales and Marketing Merck KGaA, Women in pharma, equality
Merck KGaA has set itself the goal of increasing its proportion of women managers over the next five years. The …
7 Wins for Pulsar!
February 11, 2011Medical Communications, Sales and Marketing
Pulsar have done very well of late and managed to bag 1 silver Rx award and 6 New York Rx …
Digital Pharma: AZ presses the case for social media in pharma
February 11, 2011Medical Communications AZ, AstraZeneca, Digital Pharma blog, FDA, social media
Seemingly fed up with waiting for the FDA’s delayed social media guidance, AstraZeneca has published details of its own feedback …
Shire thrives on specialist portfolio
February 11, 2011Sales and Marketing 2010 pharma results, ADHD, Shire, Vyvanse
Speciality pharma company Shire has posted sales growth of 16%, led by its ADHD treatment Vyvanse. Sales of Vyvanse rose …
Pierre Fabre loses chief executive
February 11, 2011Sales and Marketing Olivier Bohuon, Pierre Fabre, Smith & Nephew, appointment, medical devices, sales and marketing
Olivier Bohuon is leaving French pharma company Pierre Fabre after serving just five months as its chief executive. He will …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
